| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLCO1B7 KCNAB2 GRAMD1B SLC9A7 SLCO1B3 TRPA1 CYB561A3 SLC24A1 SLC14A1 SV2A SLC22A5 | 6.00e-07 | 1289 | 28 | 11 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLCO1B7 KCNAB2 SLC9A7 SLCO1B3 TRPA1 CYB561A3 SLC24A1 SLC14A1 SV2A SLC22A5 | 2.46e-06 | 1180 | 28 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.73e-05 | 42 | 28 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 4.34e-05 | 477 | 28 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 5.14e-05 | 296 | 28 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.71e-04 | 14 | 28 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.97e-04 | 15 | 28 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 2.25e-04 | 16 | 28 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 2.86e-04 | 18 | 28 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 3.19e-04 | 19 | 28 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.03e-03 | 34 | 28 | 2 | GO:0015125 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.61e-03 | 167 | 28 | 3 | GO:0015079 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.65e-03 | 43 | 28 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.55e-03 | 196 | 28 | 3 | GO:0005319 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.70e-03 | 758 | 28 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.82e-03 | 465 | 28 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.85e-03 | 227 | 28 | 3 | GO:0051015 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.32e-03 | 70 | 28 | 2 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.69e-03 | 73 | 28 | 2 | GO:0170055 | |
| GeneOntologyMolecularFunction | channel activity | 5.86e-03 | 525 | 28 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.90e-03 | 526 | 28 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 7.04e-03 | 90 | 28 | 2 | GO:0008028 | |
| GeneOntologyMolecularFunction | alcohol binding | 8.96e-03 | 102 | 28 | 2 | GO:0043178 | |
| GeneOntologyMolecularFunction | hormone binding | 9.13e-03 | 103 | 28 | 2 | GO:0042562 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 9.47e-03 | 105 | 28 | 2 | GO:0004867 | |
| GeneOntologyMolecularFunction | ATPase binding | 1.00e-02 | 108 | 28 | 2 | GO:0051117 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.08e-02 | 627 | 28 | 4 | GO:0022890 | |
| GeneOntologyCellularComponent | basal part of cell | 1.85e-04 | 378 | 30 | 5 | GO:0045178 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.08e-03 | 320 | 30 | 4 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.56e-03 | 354 | 30 | 4 | GO:0009925 | |
| GeneOntologyCellularComponent | podosome | 1.58e-03 | 41 | 30 | 2 | GO:0002102 | |
| GeneOntologyCellularComponent | sex chromosome | 1.81e-03 | 44 | 30 | 2 | GO:0000803 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.93e-03 | 223 | 30 | 3 | GO:0098862 | |
| GeneOntologyCellularComponent | lysosomal membrane | 4.09e-03 | 462 | 30 | 4 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 4.09e-03 | 462 | 30 | 4 | GO:0098852 | |
| Domain | Arp3_met | 6.50e-06 | 3 | 28 | 2 | IPR015623 | |
| Domain | MFS | 1.95e-05 | 108 | 28 | 4 | PS50850 | |
| Domain | MFS_dom | 4.54e-05 | 134 | 28 | 4 | IPR020846 | |
| Domain | OA_transporter | 1.42e-04 | 12 | 28 | 2 | IPR004156 | |
| Domain | OATP | 1.42e-04 | 12 | 28 | 2 | PF03137 | |
| Domain | Actin/actin-like_CS | 3.27e-04 | 18 | 28 | 2 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 3.65e-04 | 19 | 28 | 2 | PS01132 | |
| Domain | Actin | 9.81e-04 | 31 | 28 | 2 | IPR004000 | |
| Domain | Actin | 9.81e-04 | 31 | 28 | 2 | PF00022 | |
| Domain | ACTIN | 9.81e-04 | 31 | 28 | 2 | SM00268 | |
| Domain | Sugar_transporter_CS | 1.05e-03 | 32 | 28 | 2 | IPR005829 | |
| Domain | Sugar_tr | 1.32e-03 | 36 | 28 | 2 | PF00083 | |
| Domain | MFS_sugar_transport-like | 1.32e-03 | 36 | 28 | 2 | IPR005828 | |
| Domain | Kazal_2 | 1.32e-03 | 36 | 28 | 2 | PF07648 | |
| Domain | KAZAL_2 | 2.54e-03 | 50 | 28 | 2 | PS51465 | |
| Domain | Kazal_dom | 2.64e-03 | 51 | 28 | 2 | IPR002350 | |
| Domain | zf-C3HC4 | 4.41e-03 | 223 | 28 | 3 | PF00097 | |
| Domain | ZF_RING_1 | 9.19e-03 | 291 | 28 | 3 | PS00518 | |
| Domain | ZF_RING_2 | 9.81e-03 | 298 | 28 | 3 | PS50089 | |
| Domain | RING | 1.04e-02 | 305 | 28 | 3 | SM00184 | |
| Domain | Znf_RING | 1.25e-02 | 326 | 28 | 3 | IPR001841 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 9.54e-07 | 238 | 21 | 6 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.67e-05 | 249 | 21 | 5 | M5988 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.82e-05 | 681 | 21 | 7 | MM14985 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 1.38e-04 | 12 | 21 | 2 | MM15476 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.19e-04 | 15 | 21 | 2 | MM15697 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 3.56e-04 | 19 | 21 | 2 | MM14612 | |
| Pathway | REACTOME_HEME_DEGRADATION | 3.95e-04 | 20 | 21 | 2 | MM14721 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 4.08e-04 | 99 | 21 | 3 | M27474 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 5.48e-04 | 736 | 21 | 6 | M27287 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.02e-03 | 32 | 21 | 2 | MM14719 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 10806390 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18492796 | ||
| Pubmed | Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx. | 2.16e-06 | 3 | 30 | 2 | 28389619 | |
| Pubmed | Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics. | 2.16e-06 | 3 | 30 | 2 | 23986199 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18413659 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 18296417 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20949553 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 30955241 | ||
| Pubmed | Influence of drug formulation on OATP1B-mediated transport of paclitaxel. | 2.16e-06 | 3 | 30 | 2 | 24755470 | |
| Pubmed | OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity. | 2.16e-06 | 3 | 30 | 2 | 29337310 | |
| Pubmed | Expression of Oatp2 in the Brain and Liver of Alzheimer Disease Mouse Model. | 2.16e-06 | 3 | 30 | 2 | 31967785 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 19400585 | ||
| Pubmed | Synergistic interaction between genetics and disease on pravastatin disposition. | 2.16e-06 | 3 | 30 | 2 | 24613363 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 10833452 | ||
| Pubmed | Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain. | 4.31e-06 | 4 | 30 | 2 | 22294745 | |
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 20644253 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 25280775 | ||
| Pubmed | Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance. | 4.31e-06 | 4 | 30 | 2 | 27777271 | |
| Pubmed | Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine. | 7.18e-06 | 5 | 30 | 2 | 33819485 | |
| Pubmed | Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. | 7.18e-06 | 5 | 30 | 2 | 24698267 | |
| Pubmed | miRNA-711 Binds and Activates TRPA1 Extracellularly to Evoke Acute and Chronic Pruritus. | 7.18e-06 | 5 | 30 | 2 | 30033153 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 24194565 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.07e-05 | 344 | 30 | 5 | 30333137 | |
| Pubmed | Analysis of DNA methylation and histone modification profiles of liver-specific transporters. | 1.08e-05 | 6 | 30 | 2 | 19047482 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 22232210 | ||
| Pubmed | 3.22e-05 | 10 | 30 | 2 | 18703564 | ||
| Pubmed | 3.25e-05 | 212 | 30 | 4 | 19521566 | ||
| Pubmed | 5.58e-05 | 13 | 30 | 2 | 11682476 | ||
| Pubmed | Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | 8.57e-05 | 16 | 30 | 2 | 35307651 | |
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 1.09e-04 | 18 | 30 | 2 | 23696569 | |
| Pubmed | 1.74e-04 | 1431 | 30 | 7 | 37142655 | ||
| Pubmed | OTUB1 modulates c-IAP1 stability to regulate signalling pathways. | 1.96e-04 | 24 | 30 | 2 | 23524849 | |
| Pubmed | 3.08e-04 | 30 | 30 | 2 | 37019383 | ||
| Pubmed | 7.92e-04 | 48 | 30 | 2 | 27872092 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 2.24e-03 | 107 | 30 | 2 | chr11q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p12 | 2.50e-03 | 113 | 30 | 2 | chr12p12 | |
| Cytoband | 7q34 | 5.35e-03 | 167 | 30 | 2 | 7q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 6.52e-03 | 185 | 30 | 2 | chr7q34 | |
| GeneFamily | Solute carriers | 1.01e-05 | 395 | 24 | 6 | 752 | |
| GeneFamily | Ring finger proteins | 5.56e-03 | 275 | 24 | 3 | 58 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 5.90e-03 | 87 | 24 | 2 | 372 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-07 | 177 | 30 | 5 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-06 | 129 | 30 | 4 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.13e-06 | 162 | 30 | 4 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-06 | 168 | 30 | 4 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-06 | 175 | 30 | 4 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.13e-06 | 186 | 30 | 4 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.13e-06 | 186 | 30 | 4 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.13e-06 | 186 | 30 | 4 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 7.13e-06 | 186 | 30 | 4 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.13e-06 | 186 | 30 | 4 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.13e-06 | 186 | 30 | 4 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.13e-06 | 186 | 30 | 4 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | COVID-19_Severe-pDC|World / disease group, cell group and cell class | 7.43e-06 | 188 | 30 | 4 | 4c8e328b8206120708b05ea3c5865a0200dc5c4e | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 7.75e-06 | 190 | 30 | 4 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 7.91e-06 | 191 | 30 | 4 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 9.12e-06 | 198 | 30 | 4 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.12e-06 | 198 | 30 | 4 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | Parenchymal-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-06 | 198 | 30 | 4 | 2a00648d3aa5843d9e924e054c5e973025f86e97 | |
| ToppCell | Parenchymal-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-06 | 198 | 30 | 4 | 745e966fd52f06485061727cdbd9358b9df7d97d | |
| ToppCell | Parenchymal-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-06 | 198 | 30 | 4 | 24b1138746dd69d1cda419f7070ef5a402d07563 | |
| ToppCell | MS-Multiple_Sclerosis-Others-RBC|Multiple_Sclerosis / Disease, condition lineage and cell class | 9.30e-06 | 199 | 30 | 4 | b9e7549f67bc33284bacf9a160b3916651659809 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-erythroid-late_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.30e-06 | 199 | 30 | 4 | 5b2b5327813b44c334f81424139e6d719343966d | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-late_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.23e-05 | 92 | 30 | 3 | 3292898c81580e33c82f91b949a86bf4b5297781 | |
| ToppCell | Control-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.13e-05 | 120 | 30 | 3 | 62d3a731d36802c9da8674a042a8604cdb86263a | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-C1ql2-Excitatory_Neuron.Slc17a7.C1ql2-Cck_(Dentate_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.83e-05 | 129 | 30 | 3 | 08ecebb7f09d105dfdfd2191fc310910d3baec0f | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.25e-05 | 131 | 30 | 3 | 537a79ea2b5d6b3dc0444570b1acbceda59b0d7c | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-pDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 135 | 30 | 3 | 0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 143 | 30 | 3 | 250f60f06f262f00acd14b09b3ef90dbb9759336 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 143 | 30 | 3 | 0c7c0d7ca040e87412295672cd1f065c0e941391 | |
| ToppCell | facs-Skin-Anagen-3m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 143 | 30 | 3 | 27f4896276342758651fe7a80d7408ac5e1be9c0 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-late_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 144 | 30 | 3 | ca365380ccf5e60d2e3f6272059ff0531759612d | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 148 | 30 | 3 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 151 | 30 | 3 | 2314c004434aed9b7fa1ad01c61c43e5ed4a18ce | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-04 | 152 | 30 | 3 | 0c6dd41142e4ca1e54ca41e05e42ed29fbf0e570 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-04 | 153 | 30 | 3 | c81a88d3f707487c511020d3960a1c41e706c6a0 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.67e-04 | 160 | 30 | 3 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.67e-04 | 160 | 30 | 3 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 160 | 30 | 3 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 160 | 30 | 3 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 161 | 30 | 3 | b9a63fc9becc44d305fc7c221283bf59ec06b10f | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 164 | 30 | 3 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 165 | 30 | 3 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-late_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-04 | 166 | 30 | 3 | b4e5466a33578103d197cf67f37e7ec88e09281f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 168 | 30 | 3 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.93e-04 | 168 | 30 | 3 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 168 | 30 | 3 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-04 | 168 | 30 | 3 | 59b698f58cb206f0f8f0e8ad72b445d14ba24728 | |
| ToppCell | IIF|World / Disease, Lineage and Cell Type | 1.96e-04 | 169 | 30 | 3 | ebf726f725079317ad67c2f754748b4112607277 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 170 | 30 | 3 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l12-45|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 170 | 30 | 3 | e028e22ad051c2628248b212b5d28b891e0ee782 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-04 | 170 | 30 | 3 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 171 | 30 | 3 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.03e-04 | 171 | 30 | 3 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.03e-04 | 171 | 30 | 3 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 171 | 30 | 3 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-04 | 172 | 30 | 3 | cc1a45a35f78063b2a777ae905f70f894fbcb22f | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-04 | 172 | 30 | 3 | 3aed10e6db48254f4cae12fbe52d1a1fc6cf2dce | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.07e-04 | 172 | 30 | 3 | f0b658baa4b41329c95a09387cc55ea046e2333f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-04 | 172 | 30 | 3 | 30c57f5ca2326e8d890d9aac8096c64e5b51a24f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-04 | 172 | 30 | 3 | 8ccc3459dbdf103c631aa2a0defb8790c06ad6c1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-04 | 172 | 30 | 3 | acdc261001f63a8cfce1216ef1e33b4e034b1c11 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-04 | 174 | 30 | 3 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 174 | 30 | 3 | ce2bc1797707c3f48ef551de7edbfd7b47e5a36e | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-04 | 174 | 30 | 3 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 174 | 30 | 3 | 001254db9f4c346d06d31a7fa1213498f92e4280 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-04 | 174 | 30 | 3 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-04 | 175 | 30 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 175 | 30 | 3 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 175 | 30 | 3 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.21e-04 | 176 | 30 | 3 | 9af82b976e6a14a3ef7aa50f1f7af2463e5aa5d2 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-04 | 176 | 30 | 3 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-04 | 179 | 30 | 3 | c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35 | |
| ToppCell | Multiple_Sclerosis-Other-RBC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.32e-04 | 179 | 30 | 3 | 15763dc59ee6186416e203ffbb450ae4608eba59 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 179 | 30 | 3 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | wk_20-22-Hematologic-Meg-ery|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.40e-04 | 181 | 30 | 3 | d0637f9ccec5dba4997520b27287989522e04f96 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-04 | 181 | 30 | 3 | 577bf37a6594fad01251d2c66d8ccda8e949b6cf | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-04 | 181 | 30 | 3 | f5dc7a650afe8837cb424981e50ad2c8b18c7c32 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-04 | 181 | 30 | 3 | f4cd6dba4c04c5cb550f44468eb29c07238fbda4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-04 | 181 | 30 | 3 | c7f5d0e5aa2ca6a409957713637e1b37a73ceb60 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.44e-04 | 182 | 30 | 3 | 1adb8d6404d50155e9f9ba805abef63929fe865f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-04 | 182 | 30 | 3 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 182 | 30 | 3 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 183 | 30 | 3 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_reticulocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.48e-04 | 183 | 30 | 3 | 5470e5ac3439cfc96acd2202f6b1e386779a6637 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.48e-04 | 183 | 30 | 3 | 7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4 | |
| ToppCell | MS-IIF-Others-RBC|IIF / Disease, condition lineage and cell class | 2.52e-04 | 184 | 30 | 3 | 578bde79b464ed12dd9a53dd8e2839e156220a60 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.56e-04 | 185 | 30 | 3 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-04 | 185 | 30 | 3 | f4588468e8654363f48adbe427dff10f16f1c7fe | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-04 | 185 | 30 | 3 | 3cb816fc9541c04b4436e21d984216cfbbacff98 | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-04 | 185 | 30 | 3 | c2e70405969616c28fb6379ee318e17bbcef7b49 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.60e-04 | 186 | 30 | 3 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.60e-04 | 186 | 30 | 3 | d2fbf53aac905c9896272ec5c2db28ee1a60f4be | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-04 | 186 | 30 | 3 | d23c3318937492d7d665bec14253124c49181b5a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 186 | 30 | 3 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 2.60e-04 | 186 | 30 | 3 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | IIF-Other-RBC|IIF / Disease, Lineage and Cell Type | 2.60e-04 | 186 | 30 | 3 | db3c3fc2045c657b300b640bf228640c30782509 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 186 | 30 | 3 | 1c39ced3b32dba2832991284720b6c5f508a2e73 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.60e-04 | 186 | 30 | 3 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_reticulocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 186 | 30 | 3 | bf8ca7135c05d772aa3f5960b419a13aef3936ae | |
| ToppCell | Mild-Lymphoid-pDC-|Mild / Condition, Lineage, Cell class and cell subclass | 2.60e-04 | 186 | 30 | 3 | 1d05e73ae2ec0cc27f79e4fa40d6b21790059f80 | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 7.45e-06 | 5 | 26 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 2.68e-05 | 9 | 26 | 2 | EFO_0800562 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 5.79e-05 | 13 | 26 | 2 | EFO_0800474 | |
| Disease | X-21441 measurement | 1.01e-04 | 17 | 26 | 2 | EFO_0800814 | |
| Disease | Inflammation | 1.88e-04 | 127 | 26 | 3 | C0021368 | |
| Disease | creatine measurement | 4.62e-04 | 36 | 26 | 2 | EFO_0010472 | |
| Disease | testosterone measurement | 7.03e-04 | 1275 | 26 | 6 | EFO_0004908 | |
| Disease | cholestasis (biomarker_via_orthology) | 8.56e-04 | 49 | 26 | 2 | DOID:13580 (biomarker_via_orthology) | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 1.74e-03 | 70 | 26 | 2 | EFO_0008082 | |
| Disease | fibrinogen measurement | 4.15e-03 | 109 | 26 | 2 | EFO_0004623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HMQRYAVWFGGSMLA | 371 | Q9P1U1 | |
| FGARDRTYMMMFRLW | 186 | Q3KR37 | |
| MGKDHTMEFIYMTRW | 201 | Q86SE9 | |
| TVGQMGWFFLMAVMY | 296 | Q96A54 | |
| RQGWVVLHVFGMMYV | 451 | O60721 | |
| YLGQARHMLSKVGMW | 101 | Q9NP56 | |
| GLWHGMFANVMNKMH | 566 | Q9P265 | |
| GGMLAAWFRMKYPHM | 181 | P42785 | |
| RAMTHVINQGMAMYW | 171 | Q13303 | |
| MSLMVFGLGWRSYKH | 756 | P06401 | |
| HMQRYAVWFGGSMLA | 371 | P61158 | |
| YGMVTYLLRMMTSWA | 366 | Q86UL3 | |
| IYMFNWHPVLMVAGM | 41 | Q8NBI2 | |
| MSIMLWMTISVGYFG | 346 | O76082 | |
| MAFMVKMPLYGLHLW | 201 | P03905 | |
| AMAMKLGMAPFHFWV | 101 | P03891 | |
| YSSITHMGWMMAVLP | 181 | P03891 | |
| MMGSWLMQAGFILYR | 166 | Q5T9Z0 | |
| HFASGGMDMMVYVWT | 546 | O75083 | |
| SHMWIYVFMGNMLRG | 121 | G3V0H7 | |
| LCMFWMIGGVYAAAM | 296 | Q7L0J3 | |
| MQTHAARMRTFMYWP | 266 | Q13490 | |
| WLAYGFRAHMMNLGS | 711 | O75762 | |
| MMGEFLVAHVWGNLM | 146 | P10745 | |
| RMHMQWVSHYIMYLF | 181 | Q8N7C7 | |
| MFWRQMGGHLRMVEA | 761 | Q7Z6L1 | |
| SGSHMWIYVFMGNML | 166 | Q9NPD5 | |
| AMGGMFMALTWQTHL | 296 | Q13336 | |
| LFLMVMMTASHLYFW | 851 | Q9NYK1 | |
| YQAWQLMARGMAMEH | 521 | O15090 | |
| MNHGYMSWYRQDPGM | 46 | A0A0A6YYG3 | |
| RRHKIGWNFQHMMMF | 471 | Q96T83 | |
| GWNFQHMMMFSGLRG | 476 | Q96T83 | |
| MNHEYMSWYRQDPGM | 46 | A0A0K0K1A5 |